Life sciences · Journal article
Medicine Advances · September 19, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT Mpox, previously known as monkeypox, is an evolving zoonotic infection that raises serious public health issues, especially in low‐income settings. The recent outbreaks have indicated the existence of a need for fast, accurate and scalable diagnostics. The article under review examines how up to date convolutional neural networks may be combined with clinical knowledge in the process of early detection of mpox based on pictures of skin lesions. Among the architectures evaluated, MobileNetV2, VGG16 and GoogLeNet reported accuracy exceeding 95% in experiments conducted on publicly available datasets. While these findings demonstrate technical feasibility, such performance does not constitute evidence of clinical readiness. The reported performance reflects controlled offline validation and may be influenced by sample size, limited demographic diversity, and absence of standardized external evaluation. Future work involves building heterogeneous, labeled data sets and the integration of multi‐modal data for higher diagnostic consistency. Although deep learning‐based systems show promising experimental accuracy and computational efficiency, their integration into clinical workflows requires prospective validation, multi‐center evaluation, and regulatory assessment before real‐world deployment can be recommended.